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The human cytomegalovirus-encoded chemokine re-
ceptor US28 induces arterial smooth muscle cell (SMC)
migration; however, the underlying mechanisms in-
volved in this process are unclear. We have previously
shown that US28-mediated SMC migration occurs by a
ligand-dependent process that is sensitive to protein-
tyrosine kinase inhibitors. We demonstrate here that
US28 signals through the non-receptor protein-tyrosine
kinases Src and focal adhesion kinase (FAK) and that
this activity is necessary for US28-mediated SMC migra-
tion. In the presence of RANTES (regulated on activa-
tion normal T cell expressed and secreted), US28 stimu-
lates the production of a FAKSrc kinase complex.
Interestingly, Src co-immunoprecipitates with US28 in a
ligand-dependent manner. This association occurs ear-
lier than the formation of the FAKSrc kinase complex,
suggesting that US28 activates Src before FAK. US28
binding to RANTES also promotes the formation of a
Grb2FAK complex, which is sensitive to treatment with
the Src inhibitor PP2, further highlighting the critical
role of Src in US28 activation of FAK. Human cytomeg-
alovirus US28-mediated SMC migration is inhibited by
treatment with PP2 and through the expression of ei-
ther of two dominant negative inhibitors of FAK (F397Y
and NH2-terminal amino acids 1–401). These findings
demonstrate that activation of FAK and Src plays a crit-
ical role in US28-mediated signaling and SMC
migration.
Human cytomegalovirus (HCMV)1 is a ubiquitous herpesvi-
rus that establishes a life-long latent infection after the pri-
mary infection has been cleared. Although anti-viral therapy
has appreciably reduced disease in transplant and AIDS pa-
tients, HCMV is still a significant problem in congenital dis-
ease and bone marrow transplant patients. In addition, HCMV
has also been associated with long term diseases such as ath-
erosclerosis, restenosis after angioplasty, chronic rejection af-
ter solid organ transplantation, and malignancies (1–4). The
development of vascular disease involves a chronic inflamma-
tory process with many contributing factors, and of these,
chemokines and their receptors have been identified as key
mediators. Interestingly, HCMV encodes a CXC chemokine
(UL146), a potential CC chemokine (UL128), and four potential
chemokine receptors (US27, US28, UL33, and UL78) with the
most characterized being US28 (5–8). We have previously re-
ported that US28 mediates arterial smooth muscle cell (SMC)
migration and that this activity may contribute to viral dissem-
ination and/or acceleration of vascular disease development (9).
US28 contains homology to the CC-chemokine receptors (10)
and binds to a broad spectrum of chemokines including the CC
chemokines RANTES, MCP-1, MCP-3, and MIP-1 and the
CX3C chemokine Fractalkine/CX3CL1 (11, 12). That CC che-
mokines fail to compete out Fractalkine binding suggests that
Fractalkine binds to additional unique regions of US28 com-
pared with the CC chemokines (11). In 293 cells, RANTES
binding to US28 activates ERK1/2 pathways through the G-
proteins Gi1 and G16 (13). We have previously demonstrated
that US28-mediated SMC migration also requires chemokine
binding by either exogenously added RANTES or endogenously
expressed MCP-1 (9). Induction of US28-mediated SMC migra-
tion is not blocked by treatment with pertussis toxin, a Gi/o
inhibitor, suggesting that other G-proteins are involved in this
event. In fact, we have recently determined that US28 couples
with G12/13 to signal through RhoA.
2 This activity occurs in a
ligand-dependent manner and is required for US28-mediated
SMC migration. US28 has also been shown to exhibit consti-
tutive signaling in COS-7 cells and human fibroblasts through
both NF-B and phospholipase C pathways via activation of
Gq/11 G-proteins (14–16). Interestingly, Fractalkine binding to
US28 as well as the US28 inverse agonist (VUF2274) but not
CC chemokines antagonized constitutive signaling (15). Se-
quences have been identified in the US28 cytoplasmic domain
that mediate signaling as well as recycling from the plasma
membrane (17). Together these data highlight the fact that
there are ligand-dependent activities and cell type-specific ef-
fects occurring in US28 signaling.
Lymphocyte migration induced by ligation of chemokine re-
ceptors is generally mediated through the Gi class of hetero-
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trimeric G-proteins (18). Upon GPCR stimulation, G-proteins
bind directly to the receptor, exchanging GDP for GTP, causing
dissociation of the G subunit from the G complex. Down-
stream effectors of the activated G subunit are specific for
each type of G subunit and can include Ca2 influx, cAMP,
and phosphatidylinositol phosphate. The G heterodimer ac-
tivates signaling cascades other than those stimulated by the
G subunit, which can include the protein-tyrosine kinase
(PTK) pathways (19). For example ligand binding to CCR2,
CCR5, and CXCR1/2 induce cellular migration through the
PTK pathway (20–23). Activation of PTK(s) including that of
focal adhesion kinase (FAK) is considered central for cellular
migration. The importance of FAK in cellular migration was
demonstrated by the inability of fibroblasts isolated from
FAK/ mice to migrate in response to stimuli (24). In addi-
tion, overexpression of FAK was shown to enhance movement
of CHO cells (25), and highly invasive tumors characteristically
have heightened levels of FAK expression and activity (26–29).
FAK is comprised of a central kinase domain flanked on one
side by an N-terminal FERM (erythrocyte band 4.1-ezrin-ra-
dixin-moesin) domain, which is involved in linking FAK to
integrins and/or growth factor receptors (30). The focal adhe-
sion targeting domain is located C-terminal of the central ki-
nase domain and is comprised of multiple protein-protein in-
teraction motifs. The binding of paxillin and talin to the FAK-
FAT domain facilitates a linkage to the cytoplasmic domain of
integrins, which targets FAK to focal adhesions. FAK tyrosine
phosphorylation after integrin or growth factor stimulation of
cells is enhanced by its association with Src-family PTKs. This
leads to the formation of a multiprotein signaling complex in
which FAK serves as a scaffold. Mechanistically, after cell
stimulation, FAK autophosphorylates at Tyr-397, resulting in
the formation of an SH2 docking site. Src-family PTKs bind to
FAK at Tyr-397, become activated, and trans-phosphorylate
FAK at several other tyrosines including Tyr-925. The SH2
domain of the adaptor protein Grb2 binds to FAK Tyr-925 and
forms a signaling complex that includes the nucleotide ex-
change factor Sos and the small GTP-binding protein Ras. This
sequence of events contributes to the subsequent activation of
ERK2/mitogen-activated protein kinase.
Previously, we have reported that treatment of SMC with the
PTK inhibitors genistein or herbimycin A blocked US28-in-
duced cellular migration, suggesting that PTK activity is re-
quired for migration of these cells (9). Here we demonstrate
that US28 can signal through the non-receptor protein-tyrosine
kinases Src and FAK and that this activity is required for the
ability of US28 to mediate SMC migration. US28 activation of
FAK occurs in a ligand-dependent manner, which is contrary to
other reports suggesting that US28 may be constitutively ac-
tive. In addition, we have determined critical regions of FAK
that are required for US28-induced signaling and migration.
These findings demonstrate that FAK and Src play integral
roles in ligand-dependent, US28-mediated signaling associated
with the induction of SMC migration.
MATERIALS AND METHODS
Cell Lines and Antibodies—The life-extended human pulmonary ar-
tery smooth muscle cell line, PAT12 was maintained in Medium 199
supplemented with 20% fetal calf serum and penicillin-streptomycin-L-
glutamine (Invitrogen). For migration and in vitro kinase experiments
described below PAT1 cells were utilized between passage 5 and 30
post-telomerization. Mouse FAK/ fibroblasts were maintained on
gelatin-coated culture dishes in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum, penicillin-streptomycin-L-glu-
tamine, nonessential amino acids (Cellgro), and G418 (Sigma; 500 g/
ml) as previously described (24, 31). FAK/ cells were used in exper-
iments between passage 5 and 15.
Anti-Grb2 (C-7), anti-c-Src, anti-phosphotyrosine (PY99), and an-
ti-HA (F-7) monoclonal antibodies were purchased from Santa Cruz
Biotechnology. Phospho-specific antibodies to ERK2 (Thr-202/Tyr-204)
and total ERK2 were from Cell Signaling Technologies. Paxillin anti-
bodies (5H11) were from Upstate Biotechnologies, and anti-c-Myc tag
antibodies were from Covance. The anti-FLAG (M2) monoclonal anti-
body was from Sigma and the anti-FAK polyclonal serum was previ-
ously described (31).
FAK in Vitro Kinase Assays—To determine whether US28 promotes
the formation of an active FAK kinase complex we performed in vitro
kinase assays on immunoprecipitated FAK from human SMC (30, 31).
PAT1 SMCs were plated in 10-cm culture dishes and serum-starved for
24 h. The cells were co-infected with Ad-US28 and/or Ad-Trans at
multiplicity of infection (m.o.i.) 500. After 16 h the cells were stimulated
with RANTES (50 ng/ml) and then harvested at times 0 (unstimulated),
5, 10, and 15 min post-ligand addition. Cells were lysed in radioimmune
precipitation assay buffer containing 1% Triton X-100, 1% sodium de-
oxycholate, and 0.1% SDS, and total FAK was immunoprecipitated
using rabbit anti-FAK polyclonal serum and protein A/G-conjugated
agarose beads (Santa Cruz). Precipitation reactions were washed 1 time
in radioimmune precipitation assay buffer, 2 times in HNTG buffer (50
mM HEPES, 150 mM NaCl, 1% Triton, 10% glycerol, pH 7.4), and 2
times in kinase buffer (20 mM HEPES, 10 mM MgCl2, 10 mM MnCl2, 150
mM NaCl, 10% glycerol, pH 7.4) and then resuspended in kinase buffer
plus [-32P]ATP. The kinase reaction was allowed to proceed for 15 min
at 32 °C and then analyzed by SDS-PAGE and autoradiography. The
blots were analyzed by Western blotting for the presence of FAK and
Src.
Immunoprecipitation Reactions—FAK/ cells were plated in 10-cm
culture dishes and serum-starved for 6 h upon 75% confluence. The cells
were co-infected with Ad-Trans and/or Ad-US28 and/or Ad-FAK WT or
FAK mutants at m.o.i. 50. After 16 h the cells were stimulated with
RANTES (40 ng/ml) and then harvested at times 0 (unstimulated), 5,
10, 15, and 30 min post-ligand addition. Cells were lysed in radioim-
mune precipitation lysis buffer, total Grb2 was immunoprecipitated,
and samples were analyzed by Western blotting using antibodies di-
rected against Tyr(P). Co-precipitation of FAK-HA was demonstrated
by stripping the blots in buffer containing 0.1 M Tris, pH 6.8, 1% SDS,
and 1% 2-mercaptoethanol and staining using antibodies directed
against HA. Before immune-complex reactions, a total of 50 l of cel-
lular lysate was assayed by SDS-PAGE/Western blotting for the pres-
ence of input US28 and FAK using antibodies directed against the HA
tag present on both recombinant proteins. US28 co-immunoprecipita-
tion reactions with Src were done as described above except that we
used the FLAG-tagged version of US28, and the blots were probed with
rabbit polyclonal antibodies directed against c-Src.
SMC Migration Assay—Cell migration assays were performed as
previously described (9). Briefly, cells were added to the upper well of a
Transwell (12-mm diameter, 3.0-m pore size, Costar Corning,
Cambridge, MA) at 1  105 cells per well. Cells were serum-starved for
16–24 h. HCMV at m.o.i. 10 was added to the upper well for 2 h. After
infection the inserts were washed and transferred to fresh 12-well
plates. Cells migrating to the lower chamber were counted at 48–72 h
post-infection using a Nikon TE300 microscope at magnification 10.
Experiments were done in at least triplicate wells. Ten random fields
were read in each well. The average number of cells per well was
determined by multiplying the average number of cells per 10 field by
the number of fields per well. Mean and S.D. were calculated. PP2 (1–25
M; Calbiochem) was added 4 h after infection with HCMV to determine
the role of Src in HCMV-US28-mediated SMC migration.
For SMC migration studies involving FAK dominant negative ade-
novirus constructs, SMC were infected with HCMV (m.o.i. 10) for 2 h
followed by co-infection with Ad-Trans and Ad-FAK (WT, NT, Phe-397,
Arg-454, or Pro-) at m.o.i. of 1000 for an additional 2 h. Subsequently,
the Transwell were transferred to fresh 12-well plates. Cellular migra-
tion was determined as described above. Recombinant protein levels
were monitored by Western blotting and equalized by adjusting the
adenoviral vector m.o.i.
Adenovirus Construction—Adenoviruses expressing US28-FLAG
were previously described (9). Adenovirus vectors expressing US28 with
an N-terminal HA tag were constructed by subcloning the DNA frag-
ment (14) into pAdTet7. This vector contains the tet-responsive en-
hancer within a minimal CMV promoter followed by the SV40 late
poly(A) cassette, adenovirus E1A, and a single loxP site to increase
recombination frequency. Recombinant adenoviruses were produced by
pAdUS28-HA or pAdFAK (WT, NT, Pro, R454K, Phe-397) construct
co-transfection of 293 cells expressing the Cre recombinase with ade-
novirus DNA (Ad5-5) that contains an E1A/E3-deleted adenovirus
genome (32). Recombinant adenoviruses were expanded on 293-Cre
cells, and the bulk stocks were titered on 293 cells by limiting dilution.
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FAK and US28 expression were driven by co-infection with Ad-Trans
expressing the Tet-off transactivator as previously described (9).
Immunocytochemistry—FAK/ fibroblasts were grown in 0.1% gel-
atin-coated 4-well chamber slides (Nalge-Nunc). US28 and/or FAK was
expressed using the adenovirus vectors described above. The cells were
washed in phosphate-buffered saline, fixed in phosphate-buffered 1%
paraformaldehyde for 10 min at room temperature, permeabilized, and
blocked with 0.3% Triton X-100 in phosphate-buffered saline with 10%
fetal calf serum and 0.1% sodium azide. Thereafter, the cells were
incubated with antibodies against US28-FLAG epitope or FAK-HA
epitope or FAK-c-Myc epitope (FAK-NT mutant only) in a 1:200 dilution
for 1 h at room temperature. Cells were washed three times in phos-
phate-buffered saline, and binding of the primary antibody was de-
tected with a fluorescein isothiocyanate tetramethyl-conjugated goat
anti-mouse or rhodamine-conjugated goat anti-rabbit antibody for 1 h
at room temperature. At this time the cells were also stained for actin
using phalloidin (Molecular Probes, Eugene, OR) to monitor alterations
in cellular actin cytoskeleton induced by US28 and FAK. Fluorescence-
positive cells were visualized on an inverted Nikon fluorescent
microscope.
RESULTS
US28 Activation of FAK and Src Is Ligand-dependent—We
have previously demonstrated that the HCMV-encoded chemo-
kine receptor US28 mediates arterial SMC migration (9). Mi-
gration occurred in a ligand-dependent manner that was sen-
sitive to PTK inhibitors, suggesting a role for PTK activation in
US28-mediated SMC migration. FAK is a non-receptor PTK
with critical importance in facilitating cellular migration. To
determine whether FAK plays a role in US28-mediated SMC
migration, we first determined whether US28 ligation with
RANTES promoted the activation of FAK. For these experi-
ments, we performed in vitro kinase assays on FAK immuno-
precipitation reactions. Adenovirus vectors were used to ex-
press HCMV-US28 in PAT1 SMC using methods that have
been previously described (9). Serum-starved US28-expressing
PAT1 cells were untreated (0 time point) or treated with 50
ng/ml RANTES and harvested at 5, 10, or 15 min after the
addition of ligand. Total cellular FAK was immunoprecipitated,
and the samples were subjected to in vitro kinase assays and
examined by SDS-PAGE and autoradiography. RANTES bind-
ing to US28 promoted the formation of a FAKSrc kinase com-
plex by 5 min post-addition of ligand, and this activity was
maximal at 10 min. FAKSrc kinase activity was reduced by 15
min, suggesting that the complex is transient (Fig. 1). PAT1
cells not expressing US28 failed to promote the FAKSrc kinase
complex in the presence of RANTES (data not shown). Un-
treated US28-expressing PAT1 cells (0 time point) failed to
activate the FAKSrc kinase complex, suggesting that this
event is not due to an inherent constitutive signaling property
of US28 but, rather, requires ligand binding. Western blotting
using antibodies directed against FAK showed equal FAK pro-
tein levels for each immunoprecipitated sample, and antibodies
directed against Src confirmed the association of this protein-
tyrosine kinase with FAK (Fig. 1). Interestingly, an additional
47-kDa protein was co-immunoprecipitated with the FAKSrc
complex, and this protein was highly phosphorylated, suggest-
ing that RANTES binding to US28 facilitates the formation of
a FAK and Src kinase complex, which includes additional sig-
naling molecules.
US28 Forms a Protein Complex with Src—Previously we
demonstrated that US28-mediated SMC migration is blocked
by treatment with the pan-PTK inhibitors genistein and her-
bimycin A (9). Above we show that US28 activates a FAKSrc
kinase complex, suggesting that Src plays an important role in
US28/FAK signaling. To determine whether Src activity was
required for US28-mediated SMC migration, we performed
migration assays in the presence of increasing concentrations
of PP2. As shown in Fig. 2A, treatment of SMC expressing
US28 with PP2 resulted in near total inhibition of cellular
migration, which occurred in a dose-dependent manner. We
next examined the mechanism involved in US28 activation of
Src. We next determined whether US28 complexes with Src by
co-immunoprecipitation assays using antibodies directed
against the FLAG epitope-tagged version of US28. As shown in
Fig. 2B, antibodies directed against US28-FLAG co-precipi-
tated Src upon the addition of RANTES. The complex is formed
by 2.5 min after stimulation and is maximal between 2.5 and 5
min. The US28 association with Src returns to near back-
ground levels by 10 min (Fig. 2B). The kinetics of Src/US28
association are similar to those observed for Src/2-adrenergic
receptor binding after the addition of ligand (33). These find-
ings suggest that US28 either binds directly to Src or the
interaction is mediated through binding to other proteins like
-arrestin, as occurs with the 2-adrenergic receptor.
US28 Mediates the Association of FAK with Adaptor Proteins
in a Ligand-dependent Manner—Upon cellular activation by
extracellular matrix proteins, Src phosphorylates FAK at mul-
tiple protein binding sites and increases the ability of FAK to
bind adaptor proteins including paxillin and p190RhoGEF (fo-
cal adhesion targeting domain), Grb2 (Tyr-925), p130Cas
(PXXP motif at 712 and 876), and GRAF (PXXP motif at 876).
Binding of these adaptor proteins promotes signal transduction
and the assembly of focal adhesions. Our findings above that
US28 promotes the formation of a FAKSrc kinase complex that
contains additional phosphorylated proteins suggests that
US28 promotes the functional activation of FAK through the
binding of adaptor proteins. To determine whether US28 in-
duces the association of adaptor proteins with FAK we per-
formed FAKGrb2 co-immunoprecipitation reactions in
FAK/ cells expressing either US28-HA and/or WT FAK-HA.
Cells were treated with RANTES and harvested at 0 (unstimu-
lated), 5, 10, 15, or 30 min. Total cellular Grb2 was immuno-
precipitated, and the blots were first stained for total tyrosine
phosphorylation and then reprobed for FAK-HA. US28 pro-
moted the association of FAK with Grb2 (Fig. 3A). Interest-
ingly, only in the presence of FAK did US28 activate a highly
Tyr-phosphorylated Grb2 complex, and FAK association with
Grb2 similarly only occurred in the presence of US28. In the
US28- and FAK-expressing cells there was a higher level of Tyr
phosphorylation, suggesting that either these cells express low
levels of US28 ligands (i.e. mouse MCP-1 is a ligand for US28)
FIG. 1. US28 activates FAKSrc complex by in vitro kinase as-
says. SMC expressing US28 were untreated (0 time point) or treated
with RANTES at 5, 10, and 15 min post-stimulation. Cells were har-
vested, and total FAK was immunoprecipitated (IP) (loading control
shown in B) using anti-FAK antibodies. A, in vitro kinase assays were
performed on FAK immunoprecipitation reactions. RANTES stimula-
tion resulted in activating a FAK complex with pp60 Src between 5 and
10 min. C, Western blotting demonstrated that Src was associated with
this FAK complex.
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or that this is due to US28 constitutive activity. Interestingly,
this effect is only present in the presence of FAK. The US28
promotion of Grb2FAK complex was maximal between 5 and
15 min post-addition of RANTES (Fig. 3A), which displays
similar kinetics as US28 activation of the FAKSrc kinase com-
plex described in Fig. 1A but follows the activation of Src as
shown in Fig. 2B. Together these findings demonstrate that
US28 activation of FAKSrc kinase complex is functional and
promotes the binding of adaptor proteins to FAK.
To determine whether US28 activation of Src was critical for
FAK activation, we analyzed the regulation of FAK activation
by US28 in the presence of the Src-specific inhibitor PP2 using
Grb2FAK co-immunoprecipitation assays as described above.
Treatment with PP2 for 1 h before the addition of RANTES
blocked the ability of US28 to induce functional activation of
FAK (Fig. 3C). At a concentration of 33 M, PP2 reduced the
level of FAK binding to Grb2 to background levels of non-
stimulated US28-expressing cells. Together these findings sug-
gest that US28 activates Src and that this activity is required
for the ability of US28 to activate FAK and induce SMC
migration.
US28 mediates the activation of ERK1/2 through the Gi1
and G16 G-proteins in a ligand dependent manner (13). FAK is
also an important regulator of ERK activity through its asso-
ciation with Grb2/SOS. To determine whether US28 activation
of ERK required FAK for signal transduction, we used Western
blotting to assay the status of ERK1/2 phosphorylation in FAK-
null cells in the presence of US28 with and without FAK
reconstitution. For these experiments FAK null cells express-
ing US28-HA, FAK-HA, or US28-HA and FAK-HA were
treated with RANTES and harvested at 0 (unstimulated), 5, 10,
and 15 min after the addition of ligand. US28 activation of ERK
was ligand-dependent and occurred in the US28/FAK-express-
ing cells by 5–10 min and sustained for 15 min (Fig. 4, A and B).
However, in the absence of FAK, RANTES binding to US28
failed to activate ERK, but this activation was delayed (10 min
versus 5 min), and the levels of ERK phosphorylation were
dramatically reduced compared with cells expressing US28 in
the presence of FAK. This finding of FAK-independent activa-
tion of ERK is similar to that observed for growth factor and
integrin stimulation where activation of ERK is reduced (34).
Nonetheless the ability of US28 to activate ERK2 occurs in a
ligand- and FAK-dependent manner with kinetics that are
similar to the formation of the FAKGrb2 complex that is in-
duced by US28.
US28-mediated Cytoskeleton Rearrangements and SMC Mi-
gration Are Dependent upon FAK Activity—FAK is comprised
of a central kinase active core flanked by multiple domains that
link FAK to the cytoskeleton and promote interactions with
other adaptor proteins. Thus FAK is a scaffold for signal trans-
duction. To identify which domains of FAK are required to
transmit US28 signal transduction and mediate SMC migra-
tion, we constructed adenoviruses expressing WT FAK and
dominant negative FAK mutants (F397Y autophosphorylation/
SRC homology SH2 binding site mutant, R454K kinase inac-
tive, Pro-deleted of the proline rich regions that bind adaptor
proteins, and NT containing only the first 401 amino acids of
FAK). Fig. 5 shows the various mutants and their cellular
FIG. 2. US28 binds Src and PP2
blocks US28-mediated SMC migra-
tion. A, HCMV-US28 SMC migration as-
says were performed in the presence of
increasing concentrations of the Src
inhibitor PP2. B, US28 was immunopre-
cipitated (IP) from FAK/ fibroblasts
using antibodies directed against the
FLAG epitope at 0 (unstimulated), 2.5, 5,
and 10 min post-addition of RANTES.
Western blotting demonstrated equal
US28 loading.
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localization. All of the FAK constructs localized to focal adhe-
sions except FAK-NT, which demonstrated a disperse cytoplas-
mic-staining pattern.
US28 expression in FAK null cells failed to induce the for-
mation of Tyr-phosphorylated Grb2 complexes (Fig. 3A), sug-
gesting that the ability of US28 to signal through these adaptor
proteins requires FAK as a scaffold. FAK/ cells have a
characteristic actin morphology that lacks a coordinated net-
work of actin stress fibers, which is overcome through recon-
stitution of FAK and stimulation by extracellular matrix pro-
teins or constitutively active vSrc (32). Expression of US28 in
FAK/ cells did not alter the actin morphology in these cells
even in the presence of ligand (Fig. 6A). These results confirm
the role of FAK in US28 signaling. Reconstitution of the
FAK/ cells expressing US28 with WT FAK induced the
rearrangements in the actin cytoskeleton through the assembly
of actin stress fibers (Fig. 6B). This effect on actin morphology
was enhanced when stimulated for 2 h with RANTES (Fig. 6B)
and was absent in cells not expressing US28 (data not shown).
This suggests that activation of US28 promotes FAK-depend-
ent cytoskeleton rearrangements, which resemble the changes
in actin morphology observed in FAK reconstituted FAK/
cells expressing vSrc (32). Reconstitution with FAK-Arg-454
(kinase inactive mutant) displayed similar effects on the cellu-
lar actin structure compared with WT FAK (Fig. 6E), suggest-
ing that the kinase activity of FAK is not required for this
process. However, FAK-Phe-397 and FAK-NT failed to affect
the actin arrangement in the cells even in the presence of
ligand (Fig. 6, D and F). FAK-Pro displayed an intermediate
effect on actin morphogenesis that was only visible in the
presence of the US28 ligand (Fig. 6C). Together these findings
suggest that FAK is required in part for the ability of US28 to
mediate actin rearrangements that are associated with cellular
migration. FAK activation through the autophosphorylation/
Src binding site at Tyr-397 is critical for this activity but not
sufficient since the FAK NT mutant containing this site fails to
promote US28 morphological changes, presumably because it
lacks the FAT domain and, thus, the ability to interact with the
cytoskeleton and mediate signal transduction.
To determine whether focal adhesion kinase activity was
necessary for US28-mediated SMC migration, HCMV-infected
SMC were co-infected with adenoviruses expressing dominant
negative FAK mutants (Phe-397, R454K, Pro, or the NT mu-
tant). FAK protein expression in PAT1 SMC was determined
by Western blotting and then equalized by adjusting the ade-
novirus m.o.i. HCMV-US28 migration assays were performed
as previously described (9). HCMV-mediated SMC migration
was inhibited by the Phe-397 and NT FAK mutants, consistent
with their lack of ability to induce actin rearrangements asso-
ciated with US28 in the presence of functional FAK (Fig. 7, A
and B). Thus, US28-induced SMC migration requires the au-
tophosphorylation activity and/or downstream effects that are
associated with FAK. Interestingly, expression of WT FAK or
FAK-Arg-454 consistently enhanced HCMV-US28-mediated
SMC migration (Fig. 7, A and B), similar to the findings of Cary
et al. (25) wherein FAK overexpression in CHO cells increased
their capacity to migrate. Together with the above observations
that US28 mediates cellular cytoskeleton rearrangements
through FAK, these data suggest that the mutant lacking
FIG. 3. US28 induces FAKGrb2 complex formation. A, to determine whether US28 promotes the association of FAK with the adaptor
protein Grb2, co-immunoprecipitation reactions were performed. FAK/ cells expressing US28, WT FAK, or US28 and WT FAK were stimulated
with RANTES and harvested at 0 (unstimulated), 5, 10, 15, 30 min post-addition of ligand. Cells were lysed in a modified radioimmune
precipitation lysis buffer, and total cellular Grb2 was immunoprecipitated (IP) using specific antibodies and protein A/G-conjugated Sepharose
beads. Samples were analyzed by SDS-PAGE and Western blotting (WB) first for Tyr(P) (P-Tyr) and then FAK-HA. B, Western blot demonstrating
equal expression of FAK and US28. C, to determine whether Src activity was required for US28-mediated activation of FAK, US28 expressing
FAK-reconstituted FAK null cells were treated with increasing concentrations of PP2 before activation with RANTES. At 0 (unstimulated) and 10
min post-RANTES addition, samples were harvested, and Grb2FAK coimmunoprecipitation reactions using antibodies to Grb2 were performed as
described above. The samples were analyzed by SDS-PAGE and Western blotting using antibodies directed against FAK-HA tag.
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kinase activity can still function with wild-type properties. The
FAK-Pro caused an intermediate phenotype as overexpression
of this mutant did not block SMC migration nor did it enhance
migration. This intermediate effect was similar to the effect of
this mutant on promoting alterations in cellular morphology.
Overall our findings demonstrate an important role for FAK
and Src in ligand-dependent, US28-mediated signaling and
SMC migration.
DISCUSSION
In this study, we demonstrate that US28 signals through the
non-receptor tyrosine kinases FAK and Src in a ligand-depend-
ent manner and that this activity has a direct role in HCMV-
mediated SMC migration. These observations suggest a model
(Fig. 8) whereby ligand binding to the HCMV-US28 chemokine
receptor binds and activates Src, which then promotes FAK
activation through the phosphorylation of critical sites on FAK
FIG. 5. Construction of adenovirus
vectors expressing FAK mutants.
Shown is a schematic map and immuno-
fluorescence analysis of WT FAK and the
FAK mutants (Phe-397, NT, Arg-454, and
Pro). FAK-expressing cells were stained
with antibodies directed against the FAK-
N-terminal HA tag (green) or N-terminal
C-Myc tag (green; FAK-NT), actin was
stained with phalloidin (red), and nuclei
were stained with Hoescht dye (blue).
F.A.T., focal adhesion targeting; P-,
phosphorylated.
FIG. 4. US28 activation of ERK requires FAK. To determine whether US28 activation of ERK requires FAK, we performed Western blot
analysis for active ERK using phospho (P)-specific ERK antibodies. FAK null cells expressing either US28 alone, WT FAK alone, or US28 and WT
FAK were stimulated with RANTES and harvested at 0 (unstimulated), 5, 10, 15, and 30 min post-addition of ligand. To demonstrate equal ERK
loading, the above blots were reprobed for total ERK.
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that mediate protein-protein interactions with adaptor pro-
teins such as Grb2. Activation of Grb2/Sos promotes the acti-
vation of ERK1/2 through RAS, which is important to initiate
transcriptional events necessary for cellular migration. In the
FAK-reconstituted FAK/ cells we observed that US28 sig-
naling induced the rearrangement of the actin cytoskeleton,
which is necessary for the induction of migration. Thus, FAK
and Src play a central role in US28-mediated signaling and
migration through promotion of focal adhesion formation/dis-
assembly and cytoskeleton rearrangements that are critical for
motility.
US28 Activation of Src and FAK—US28 can signal in re-
sponse to ligand binding and also in the absence of the addition
of exogenous ligands. Interestingly, the types of signaling path-
ways that are evoked in the presence or absence of US28
ligands are dramatically different. Physiological relevant path-
ways need to be used in functional assays to determine the
relevance of the signaling observed in constitutive versus ligand-
dependent pathways. Although constitutive US28 signaling
may occur during the life cycle of HCMV infection, a physio-
logical role for this event has not been identified. However, our
studies indicate that US28 ligand binding induces SMC migra-
tion, which is dependent upon the signaling events involved in
this process.
Inhibition of Src with PP2 abrogated US28-mediated SMC
migration, suggesting a functional relationship of Src in US28-
mediated SMC migration. US28 activation of Src occurs before
that of FAK since the US28 Src interaction occurred before the
activation of FAK and since inhibition of Src blocked FAK
association with Grb2. A number of mechanisms have been
implicated in the activation of Src by GPCRs. However, cur-
rently ligand binding to a GPCR is considered to promote the
release of the G-protein  subunits, which then target G-
protein-coupled receptor kinases to the activated receptor.
FIG. 6. US28-induced actin stress fiber formation is FAK-dependent. FAK null cells expressing US28 were lacking FAK (A) or reconsti-
tuted with WT FAK (B) or the FAK mutants Pro (C), Phe-397 (D), Arg-454 (E), or NT (F). RANTES-treated cells were fixed 2 h post-addition of
ligand. Cells were stained for actin with phalloidin, for FAK using antibodies directed against the FAK-N-terminal HA tag or c-Myc tag (NT-FAK
only), and for US28 using antibodies directed against the N-terminal FLAG epitope present on US28.
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G-protein-coupled receptor kinases promote receptor internal-
ization and the association of the GPCR with arrestins. Src is
targeted to the active receptor-arrestin complex because they
contain Src binding domains. Interestingly, we demonstrate
here that US28 forms a complex with Src in the presence of
RANTES, which may occur via a direct interaction or through
binding of adaptor proteins like -arrestin. However, two inde-
pendent groups have provided conflicting data with regard to
the association of US28 with -arrestin. One group has shown
that US28 C-terminal tail sequences are responsible for the
interaction of US28 and G-protein-coupled receptor kinases
and/or -arrestin and they also demonstrate the importance of
this region in ligand-independent signaling through phosphati-
dylinositol 1,4,5-trisphosphate and p38 (35). However, a differ-
FIG. 7. FAK activity is required for US28-mediated SMC migration. To determine whether FAK activity was necessary for US28-mediated
SMC migration, HCMV-infected SMC were co-infected with adenoviruses expressing dominant negative FAK mutants (Phe-397, R454K, and Pro
in A or WT FAK, Phe-397, and NT in B). HCMV-mediated SMC migration was inhibited by the NT and Phe-397 mutants. FAK mutant protein
expression was determined by Western blotting using antibodies directed against an N-terminal HA tag.
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ent report demonstrates that US28 internalization is not al-
tered in -arrestin/ fibroblasts, although this second study
failed to determine whether US28 signaling was altered in
these cells (36). Thus, the mechanisms of ligand-dependent
US28 activation of Src require further investigation.
RANTES binding to the cellular CC-chemokine receptor
CCR5 is also known to activate FAK in T-cells. Interestingly,
AOP-RANTES, a derivative of RANTES that binds CCR5 with
similar kinetics as RANTES, does not induce T-cell migration
and failed to activate FAK, indicating that FAK activation is
important for cellular migration (22). Here we demonstrate
that US28 activates FAK upon RANTES binding. Activation of
FAK was crucial for the induction of SMC migration as two
independent mutants of FAK (F397Y and NT) were capable of
blocking US28-induced motility. This is the first demonstration
that expression of the FAK FERM domain (FAK-NT) can act as
a dominant inhibitor of migration. The FAK-F397Y mutant is
capable of localizing to focal adhesions but fails to interact with
Src, rendering this FAK molecule unable to become activated
or transduce signals. The mechanism of the FAK-NT mutant in
blocking US28-mediated SMC migration is not fully under-
stood but may work by sequestering active Src because it con-
tains a natural autophophorylation/SH2 binding domain (30).
These results demonstrate the critical role of FAK activation in
US28 mediated signaling events that occur before the induc-
tion of migration.
US28 in the Signaling and Migration Processes Associated
with Disease—The ability of US28 to mediate cellular migra-
tion distinguishes this GPCR from other virus-encoded chemo-
kine receptors. Previously, we demonstrated that US28 medi-
ates the migration of arterial SMC. This migration may have
important implications in the development of vascular diseases
through the increased movement of these cells in and around
vascular lesions. However, US28 may alter or enhance the
migratory capacity of a number of other cell types yet to be
explored. For instance, HCMV establishes latency in hemato-
poietic progenitor cells and monocytes, and these cells are
subject to extensive chemokine binding potentials under in-
flammatory conditions. Interestingly, the promonocytic cell
line THP-1 has been reported to express US28 in the absence of
viral early or late genes, suggesting that US28 may be ex-
pressed during the non-productive phase of virus replication
(37). If US28 is expressed in monocytes or progenitor cells, the
virus may be able to direct or target these virus-infected cells to
areas of local inflammation through US28 binding to RANTES,
MCP-1, or even the endothelial cell membrane-bound chemo-
kine Fractalkine. HCMV has acquired many different strate-
gies of immune evasion; US28 expression in these cells may
misdirect virus-infected monocytes to sites of inflammation
instead of the lymph node structures involved in the normal
antigen retrieval/presentation arm of the immune system. In
HCMV biology this concept actually makes sense because in-
flammatory conditions promote reactivation and replication of
this herpesvirus. Thus, targeting areas of inflammation by
infected cells would be favorable for HCMV persistence. In
support of this hypothesis, a number of studies indicate that
deletion of the viral chemokine receptor homologues to HCMV-
UL33 in mouse CMV and rat CMV, m33 and r33 respectively,
results in the lack of virus replication in the host salivary
glands (38, 39). The viral GPCRs may mediate this process
through expression in CMV-infected macrophages, which al-
ters migration of these cells to different tissues.
Our studies suggest that one of the critical mechanisms
involved in HCMV-US28-mediated SMC migration is the acti-
vation of the PTK focal adhesion kinase. Because US28 activa-
tion of FAK and SMC migration was sensitive to the drug PP2,
FIG. 8. Model of FAK and Src in
US28-mediated signaling and SMC
migration. RANTES binding to US28
promotes interactions with and activation
of Src, which then mediates the formation
of an active FAKSrc kinase complex. Src
phosphorylates FAK at a number of sites
including the Grb2 binding domain (Tyr-
925), which promotes the activation of
Grb2/Sos. Thus, FAK acts as a signaling
scaffold to promote US28-mediated SMC
migration.
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which is potent inhibitor of Src, and because US28 activates a
FAKSrc kinase complex, it may be suggested that Src plays an
important role in US28 activation of FAK. FAK and Src are
important modulators in a number of cellular processes and are
implicated in a number of disease states. Because HCMV is
associated with vascular disease as well as tumors that are
highly invasive, the linking of US28 to activation of FAK and
Src may have significant implications in these diseases.
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